2025年4月6日 周日
Home > Archive>Volume 28, Issue 8, 2020 >733-736
PDF HTML XML Export Cite reminder
The research progress of lipoxin and metabolic diseases
CSTR:
[cstr]
Author:
Affiliation:

1.Department of Clinical Laboratory, the Gaoping District People's Hospital of Nanchong, Nanchong, Sichuan 637100, China;2.Research Center for Transformation of Medical Studies, North Sichuan Medical College, Nanchong, Sichuan 637000, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [37]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Lipoxins (LX), metabolites of arachidonic acid, are one of the most important endogenous lipid mediators which initiate inhibition in ammatory reaction as well as promote extinction of in ammation resolution. Nowadays, the role of LX in diabetes, obesity, cardiovascular disease and other metabolic diseases has attracted wide attention. Therefore, this paper reviews the biological function of LX and its research progress in metabolic diseases.

    Reference
    [1] Serhan CN, Hamberg M.Lipoxins:novel series of biologically active compounds formed from arachidonic acid in human leukocytes.Proc Natl Acad Sci USA, 4,1(17):5335-5339.
    [2] Serhan CN, Sheppard KA.Lipoxin formation during human neutrophil-platelet interactions evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.J Clin Invest, 0,5(3):772-780.
    [3] Serhan CN.Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.Prostag Leukotr Ess, 5,3(3-4):141-162.
    [4] Gronert K, Chiang N, Serhan CN, et al.Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.Am J Pathol, 1,8(1):3-9.
    [5] Chiang N, Serhan CN, Dahlén SE, et al.The lipoxin receptor ALX:potent ligand-specific and stereoselective actions in vivo.Pharmacol Rev, 6,8(3):463-487.
    [6] Yacoubian S, Serhan CN.Newendogenousanti-inflammatory andproresolvinglipidmediators:implicationsforrheumatic diseases.Nat Clin Pract Rheumatol, 7,3(10):570-579.
    [7] Wu SH, Liu B, Dong L, et al.NF-kappa B is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein.Exp Dermatol, 0,9(8):286-288.
    [8] Morris T, Stables M, Paul CN, et al.Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.Proc Natl Acad Sci USA, 0,7(19):8842-8847.
    [9] Baker N, O'Meara SJ, Scannel lM, et al.Lipoxin A4:anti-inflammatory and anti-angiogenic impact on endothelial cells.J Immunol, 9,2(6):3819-3826.
    [10] Lin F, Yu X, Zhang X, et al.A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats.Placenta, 3,4(10):941-948.
    [11] Hsu CC, Huang HC, Wu PT, et al.Sesame oil improves functional recovery by attenuating nerve oxidative stress in a mouse model of acute peripheral nerve injury:role of Nrf-2.J Nutr Biochem, 6,8:102-106.
    [12] Kim KM, Heo DR, Kim YA, et al.Coniferaldehyde inhibits LPS-induced apoptosis through the PKCα/βII/Nrf-2/HO-1dependent pathway in RAW264.7 macrophage cells.Environ Toxicol Phar, 6,8:85-93.
    [13] Zhang L, Wu P, Jin SW, et al.Lipoxin A4 negatively regulates lipopolys accharide-induced differentiatiion of RAW264.7 murine macrophages into dendritic-like cells.Chin Med J (Engl), 7,0(11):981-987.
    [14] 陈晓红, 舒赛男, 刘兴楼, 等.脂氧素受体激动剂对巨细胞病毒感染巨噬细胞的免疫负调节.中国组织工程研究, 3,7(5):886-893.
    [15] Han JQ, Liu CL, Wang ZY, et al.Anti-inflammatory properties of lipoxin A4 protect against diabetes mellitus complicated by focal cerebral ischemia/reperr- fusion injury.Neural Regeneration Reserch, 6,1(4):636-640.
    [16] Wu L, Miao S, Zou LB, et al.Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.J Mol Neurosci, 2,8(1):185-200.
    [17] Chen Z, WuZ, Huang C, et al.Effectof lipoxin A4 on myocardial ischemia reperfusion injury following cardiac arrest in a rabbit model.Inflammation, 3,6(2):468-475.
    [18] Zong L, Li J, Chen X, et al.Lipoxin A4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer.Oxid Med Cell Longev, 6,6:6815727.
    [19] Higgins G, Buchanan P, Perriere M, et al.Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.Am J Respir Cell Mol Biol, 4,1(2):178-190.
    [20] Das UN.Arachidonic acid and lipoxin A4 as possible endogenous antidiabetic molecules.Prostag Leukotr Ess, 3,8(3):201-210.
    [21] Das UN.Is there a role for bioactive lipids in the pathobiology of diabetes mellitus?.Front Endocrinol, 7,8:182.
    [22] Brennan EP, Mohan M, Mcclelland A, et al.Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease.J Am Soc Nephrol, 8,9(5):1437-1448.
    [23] 徐峰, 韩庆龙, 郭巍, 等.脂氧素A4与2型糖尿病早期肾脏疾病相关性观察.中国糖尿病杂志, 8,6(9):740-743.
    [24] 张志月, 房辉, 李玉凯, 等.糖尿病视网膜病变患者血清脂氧素A4和血管内皮生长因子的相关性研究.中国现代医学杂志, 6,6(7):15-19.
    [25] Brgeson E, Sharma K.Obesity, immunomodulation and chronic kidney disease.Curr Opin Pharmacol, 3,3(4):618-624.
    [26] Donath MY, Dalmas , et al.Inflammation in obesity and diabetes:islet dysfunction and therapeutic opportunity.Cell Metab, 3,7(6):860-872.
    [27] Masoodi M, Kuda O, Rossmeisl M, et al.Lipid signaling in adipose tissue:connecting inflammation & metabolism.Biochim Biophys Acta, 5,1(4):503-518.
    [28] Huang YH, Wang HM, et al.Lipoxin A4 inhibits NF-κB activation and cell cycle progression in RAW264.7 cells.Inflammation, 4,7(4):1084-1090.
    [29] Brgeson E, Johnson AM, Lee YS, et al.Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease.Cell Metab, 5,2(1):125-137.
    [30] Brgeson E, Mcgillicuddy FC, Harford KA, et a1.Lipoxin A4 attenuates adipose inflammation.FASEB J, 2,6(10):4287-4294.
    [31] Jiang H, Li LL.Detection value of myeloperoxidase and lipoxin A4 in patients with coronary atherosclerotic heart disease.Med J Community, 7,5(8):38-40.
    [32] Kronke G, Katzenbeisser J, Uderhardt S, et al.12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis.J Immunol, 9,3(5):3383-3389.
    [33] Lu T, Parthasarathy S, Hao H, et al.Reactive oxygen species mediate oxidized low-density lipoprotein-induced inhibition of oct-4 expression and endothelial differentiation of bone marrow stem cells.AntioxidRedox Signal, 0,3(12):1845-1856.
    [34] 张鹏, 张冬颖, 覃数.12/15-脂氧合酶与心血管疾病.心血管病学进展, 4,5(4):495-498.
    [35] Ho KJ, Spite M, Owens CD, et al.Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.Am J Pathol, 0,7(4):2116-2123.
    [36] Petri MH, Laguna-Fernandez A, Arnardottir H, et al.Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E－/－mice.Br J Pharmacol, 7,4(22):4043-4054.
    [37] 赵琦峰, 夏杰, 邵兰, 等.脂氧素A4对心肌缺血再灌注损伤大鼠细胞因子和氧化应激的影响.医学研究杂志, 3,2(4):151-155.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Lizhu, LONG Fan, ZHONG Xiaowu, LI Jiulong. The research progress of lipoxin and metabolic diseases[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(8):733-736.

Copy
Share
Article Metrics
  • Abstract:953
  • PDF: 915
  • HTML: 0
  • Cited by: 0
History
  • Received:September 03,2019
  • Revised:October 27,2019
  • Online: July 03,2020
Article QR Code

You are the 27917 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025